文献速递免疫规划

通过调节血凝素裂解位点和聚合酶酸性X移码位点开发鸡胚内兼容的NS1截短型减毒活流感疫苗

Development of in ovo-compatible NS1-truncated live attenuated influenza vaccines by modulation of hemagglutinin cleavage and polymerase acidic X frameshifting sites.
PubMed 文献 · Vaccine · 2023-01-18

研究旨在改造高干扰素诱导性减毒活流感疫苗以实现鸡胚内接种兼容性。将H7疫苗病毒血凝素裂解位点替换为H6亚型序列并破坏聚合酶酸性X蛋白移码位点后,鸡胚内接种最高10^5半数鸡胚感染剂量对孵化率影响极小,并在两周龄时保护鸡抵抗异源攻击病毒。

要点

  • 高干扰素诱导性减毒活疫苗本身不足以在鸡胚内减毒。
  • 替换血凝素裂解位点并破坏聚合酶酸性X移码位点可降低鸡胚致病性。
  • 改造后疫苗鸡胚内接种最高10^5半数鸡胚感染剂量对孵化率影响极小,两周龄时保护鸡抵抗异源攻击病毒。

核心结论

  • 靶向基因突变可进一步减毒并提高减毒活流感疫苗的安全性,以开发未来的禽用鸡胚内疫苗。

研究设计与样本

  • 研究对高干扰素诱导性减毒活流感疫苗候选株进行基因改造,替换H7疫苗病毒血凝素裂解位点(PENPKTR/GL)为H6亚型病毒序列(PQIETR/GL),并破坏负责病毒聚合酶酸性X蛋白表达的核糖体移码位点,随后在鸡胚内接种鸡并评估孵化率及两周龄时对异源攻击病毒的保护。

主要发现

  • 高干扰素诱导性疫苗增强的干扰素反应不足以在鸡胚内减毒。
  • 鸡胚内接种最高10^5半数鸡胚感染剂量的改造疫苗对孵化率影响极小。
  • 改造疫苗在鸡两周龄时保护其抵抗异源攻击病毒。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Emerging avian influenza viruses pose a high risk to poultry production, necessitating the need for more broadly protective vaccines. Live attenuated influenza vaccines offer excellent protective efficacies but their use in poultry farms is discouraged due to safety concerns related to emergence of reassortant viruses. Vaccination of chicken embryos inside eggs (in ovo) induces early immunity in young chicks while reduces the safety concerns related to the use of live vaccines on farms. However, in ovo vaccination using influenza viruses severely affects the egg hatchability. We previously engineered a high interferon-inducing live attenuated influenza vaccine candidate with an enhanced protective efficacy in chickens. Here, we asked whether we could further modify this high interferon-inducing vaccine candidate to develop an in ovo-compatible live attenuated influenza vaccine. We first showed that the enhanced interferon responses induced by the vaccine is not enough to attenuate the virus in ovo. To reduce the pathogenicity of the virus for chicken embryos, we replaced the hemagglutinin cleavage site of the H7 vaccine virus (PENPKTR/GL) with that of the H6-subtype viruses (PQIETR/GL) and disrupted the ribosomal frameshifting site responsible for viral polymerase acidic X protein expression. In ovo vaccination of chickens with up to 105 median egg infectious dose of the modified vaccine had minimal effects on hatchability while protecting the chickens against a heterologous challenge virus at two weeks of age. This study demonstrates that targeted genetic mutations can be applied to further attenuate and enhance the safety of live attenuated influenza vaccines to develop future in ovo vaccines for poultry.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Ghorbani A, Ngunjiri JM, Edward C Abundo M, et al. Development of in ovo-compatible NS1-truncated live attenuated influenza vaccines by modulation of hemagglutinin cleavage and polymerase acidic X frameshifting sites. Vaccine. 2023. PMID: 36669965. doi:10.1016/j.vaccine.2023.01.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。